Salivary duct carcinoma: Clinical outcomes and prognostic factors in 157 patients and results of androgen deprivation therapy in recurrent disease (n=31)—Study of the Dutch head and neck society (DHNS).

Eline Boon,Max Witjes,Robert J.J Van Es,Stefan M Willems,Sjoukje Oosting,Laura Smit,Lilly-Ann Van Der Velden,Simone Eerenstein,Robert Baatenburg De Jong,Miranda Bel,Carla M.L Van Herpen,Michiel Van Den Brekel,Elisabeth Bloemena,Winette Ta Van Der Graaf,Ann Hoeben,Uta E Flucke

doi:10.1200/jco.2016.34.15_suppl.6016

Salivary duct carcinoma: Clinical outcomes and prognostic factors in 157 patients and results of androgen deprivation therapy in recurrent disease (n=31)—Study of the Dutch head and neck society (DHNS).

Eline Boon, Max Witjes + Show 14 more

https://doi.org/10.1200/jco.2016.34.15_suppl.6016

Copy DOI

Export

Save

Cite

Journal: Journal of Clinical Oncology	Publication Date: May 20, 2016
Citations: 8

Affiliation: Radboud University Nijmegen, Radboud University Nijmegen Medical Centre, University Medical Center Groningen, University Medical Center Utrecht, Utrecht University, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Leiden University Medical Center, Amsterdam UMC Location VUmc, Erasmus MC, Maastricht University

#Salivary Duct Carcinoma #Therapy In Recurrent Disease #Neck Society #Androgen Receptor #Aggressive Subtype Of Cancer #Prognostic Factors #Clinical Prognostic Factors #Recurrent Disease #Clinical Outcomes #Subtype Of Cancer

Abstract
Full-Text
Similar Papers

Abstract

Listen

6016Background: Salivary Duct Carcinoma (SDC) is a rare, highly aggressive subtype of salivary gland cancer, which is androgen receptor (AR) positive in most pts. In recurrent disease androgen depr...

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Clinical Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Salivary duct carcinoma: Clinical outcomes and prognostic factors in 157 patients and results of androgen deprivation therapy in recurrent disease (n=31)—Study of the Dutch head and neck society (DHNS).